| Literature DB >> 35422786 |
Yu-Chieh Liao1, Han-Chieh Wu2, Ci-Hong Liou2, Tsai-Ling Yang Lauderdale2,3, I-Wen Huang2, Jui-Fen Lai2, Feng-Jui Chen2,3.
Abstract
Molecular typing is an essential tool that has been extensively applied in laboratories as well as in clinical settings. Next-generation sequencing technologies promise high-throughput and cost-effective molecular applications; however, the accessibility of these technologies is limited due to the high capital cost. Oxford Nanopore Technologies (ONT) offers a MinION device with the advantages of real-time data analysis, rapid library preparation, and low cost per test. However, the advantages of the MinION device are often overshadowed by its lower raw accuracy. Herein, we present a concise multilocus sequence typing protocol of Staphylococcus aureus using multiplex polymerase chain reaction and Rapid Barcoding Kit for barcoding and MinION device for sequencing. Moreover, to clarify the effects of carryover DNA on tasks that require high sequence accuracy, we used the MinION flow cell in successive runs of washing and reusing. Our results revealed that the MinION flow cell could achieve accurate typing of a total of 467 samples with 3,269 kilobase-long genes within a total of 5 runs. This thus demonstrates the effectiveness of a portable nanopore MinION sequencer in providing accurate, rapid, and routine molecular typing.Entities:
Keywords: MinION; molecular typing; multilocus sequence typing; multiplex polymerase chain reaction; nanopore sequencing
Year: 2022 PMID: 35422786 PMCID: PMC9002326 DOI: 10.3389/fmicb.2022.875347
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Schematic workflows of (A) dual-barcode system (Liou et al., 2020) and (B) rapid multiplex polymerase chain reaction (PCR) and barcoding protocol.
Summary of MinION nanopore sequencing results.
| Run | Available pores | Run time | Read counts | Passed reads | Passed (%) | Barcoded reads | Unclassified (%) | Average barcoded reads |
|---|---|---|---|---|---|---|---|---|
| Run1 | 830 | 3 h 39 m 9 s | 934,114 | 829,160 | 88.8 | 786,375 | 5.2 | 8191.4 ± 1963.2 |
| Run2 | 572 | 3 h 56 m 24 s | 983,673 | 849,178 | 86.3 | 803,037 | 5.4 | 8365.0 ± 1911.2 |
| Run3 | 510 | 5 h 3 m 47 s | 1,021,596 | 843,838 | 82.6 | 795,398 | 5.7 | 8285.4 ± 1932.1 |
| Run4 | 379 | 9 h 47 m 53 s | 998,293 | 765,018 | 76.6 | 716,831 | 6.3 | 7467.0 ± 1552.1 |
| Run5 | 325 | 48 h 2 m 24 s | 1,092,802 | 764,021 | 69.9 | 707,887 | 7.3 | 7373.8 ± 1828.7 |
Figure 2Distributions of sequencing reads on the first flow cell (A) and the second flow cell (B). Arrows indicate samples labeled as low sequencing depth (LSD). In (A), 88 polymerase chain reaction (PCR) products in Run4 highlighted with background colors to indicate aliquots of amplicons in Run2 that were rapid barcoded with different barcodes; the other 8 PCR products in Run4 were from 8 isolates (Sau 289–296). Run1–Run5 in (B) containing identical PCR products in Run2, Run3, Run5, Run1, and Run3 in (A), respectively.
Figure 3Boxplot of sequencing reads across genes and runs.
Krocus sequence type (ST) prediction for Staphylococcus aureus.
| Krocus result | Number of samples | |||||
|---|---|---|---|---|---|---|
| Coverage | Prediction | Run1 | Run2 | Run3 | Run4 | Run5 |
| 100 | ST | 83 | 91 | 89 | 91 | 85 |
| ≧99 | ST | 8 | 1 | 2 | 2 | 2 |
| 100 | ND | 2 | 3 | 3 | 2 | 1 |
| ≧99 | ND | 0 | 0 | 0 | 0 | 2 |
| <99 | ND |
|
|
|
|
|
ST: sequence type predicted by Krocus; ND: sequence type not determined by Krocus.
Boldface indicates the number of samples labeled as low sequencing depth (LSD).
Alleles prediction inconsistencies between Krocus and nanoMLST2.
| Run | BC | Krocus | nanoMLST2 | Sanger | ||
|---|---|---|---|---|---|---|
| ST | Cov | Allele | ||||
| 1 | 03 | 15 | 99.68 |
|
| |
| 1 | 16 | 623 | 99.65 |
|
| |
| 1 | 32 | 7 | 99.71 |
|
| |
| 1 | 36 | 59 | 100 |
|
| |
| 1 | 43 | ND | 100 |
|
| |
| 1 | 59 | 1 | 99.71 |
|
| |
| 1 | 65 | 25 | 99.71 |
|
| |
| 1 | 70 | 22 | 99.77 |
|
| |
| 1 | 72 | 239 | 99.77 |
|
| |
| 1 | 93 | ND | 100 | New ST | ||
| 1 | 94 | 5,535 | 99.87 |
|
| |
| 2 | 46 | ND | 100 |
|
| |
| 2 | 77 | ND | 100 |
|
| |
| 2 | 89 | ND | 100 |
|
| |
| 3 | 13 | 59 | 100 |
|
| |
| 3 | 29 | 188 | 100 |
|
| |
| 3 | 39 | 398 | 100 |
|
| |
| 3 | 41 | ND | 100 | New ST | ||
| 3 | 42 | ND | 100 |
|
| |
| 3 | 48 | 291 | 100 |
|
| |
| 3 | 51 | ND | 100 |
|
| |
| 3 | 80 | 4,567 | 99.65 |
|
| |
| 4 | 01 | ND | 100 |
|
| |
| 4 | 85 | ND | 100 |
|
| |
| 5 | 04 | 188 | 99.68 |
|
| |
| 5 | 35 | ND | 99.94 |
|
| |
| 5 | 36 | ND | 100 |
|
| |
| 5 | 37 | ND | 99.74 |
|
| |
| 5 | 59 | 7 | 100 |
|
| |
Asterisks represent alleles partially covered using Krocus (Page and Keane, 2018), strikethroughs represent wrong predictions, and boldface represents allele prediction consistency between Krocus and Sanger sequencing.
Boldface represents consistency in consensus sequences between nanoMLST2 and Sanger sequencing.
Underlines represent new Sanger-sequenced alleles identified in this study, and # represents alleles that were Sanger sequenced previously (Liou et al., 2020).